HIGH NET WORTH ADVISORY GROUP LLC Neurocrine Biosciences, Inc. Transaction History

HIGH NET WORTH ADVISORY GROUP LLC portfolio value:

$106,000
portfolio value

HIGH NET WORTH ADVISORY GROUP LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 9K $106.21 1K
Q2 2022 share 0.00% 0 shares 3K $97.48 1K
Q1 2022 share 0.00% 0 shares 9K $93.75 1K
Q4 2021 share Increase 0.00% 1K shares 75K $84.63 1K